News
SSKN
0.5600
+3.70%
0.0200
Weekly Report: what happened at SSKN last week (0415-0419)?
Weekly Report · 2d ago
Weekly Report: what happened at SSKN last week (0408-0412)?
Weekly Report · 04/15 12:01
STRATA Skin Sciences renews distribution agreements in China and Japan
STRATA Skin Sciences renews distribution agreements in China and Japan. The terms of each of the distribution agreements are for three years and carry minimum unit placements and purchases of the XTRAC and VTRAC devices. STRATA skin Sciences, Inc. Has renewed two distinct distribution agreements.
Seeking Alpha · 04/09 12:40
STRATA SKIN SCIENCES ANNOUNCES RENEWAL OF EXCLUSIVE DISTRIBUTION AGREEMENTS IN CHINA AND JAPAN
Reuters · 04/09 12:30
Weekly Report: what happened at SSKN last week (0401-0405)?
Weekly Report · 04/08 12:08
Weekly Report: what happened at SSKN last week (0325-0329)?
Weekly Report · 04/01 12:04
SSKN Stock Earnings: Strata Skin Sciences Misses EPS, Misses Revenue for Q4 2023
Strata Skin Sciences reported earnings per share of -4 cents. The company reported revenue of $8.69 million. This was 13.20% worse than the analyst estimate for the company to report revenue of $10.01 million. The company also reported lower-than-expected revenue.
Investorplace · 03/28 00:53
STRATA Skin Sciences Unveils Annual Financial Results
TipRanks · 03/27 21:03
STRATA Skin Sciences Inc reports results for the quarter ended in December - Earnings Summary
STRATA Skin Sciences Inc reports results for the quarter ended in December. The company reported a quarterly adjusted loss of 11 cents per share. Revenue fell 41.4% to $6.21 million from a year ago. The average analyst rating on the shares is "strong buy"
Reuters · 03/27 21:01
Strata Skin Sciences Q4 EPS $(0.04) Misses $(0.02) Estimate, Sales $8.69M Miss $10.01M Estimate
Strata Skin Sciences reported quarterly losses of $0.04 per share. The company reported quarterly sales of $8.69 million which missed the analyst consensus estimate of $10.01 million by 13.20%. The company also reported a 700 percent decrease in sales from last year.
Benzinga · 03/27 20:52
12 Health Care Stocks Moving In Wednesday's After-Market Session
Avalo Therapeutics (NASDAQ:AVTX) shares moved upwards by 215.8% to $15.0 during Wednesday's after-market session. The company's Q4 earnings report came out today. Fresh2 Group stock rose upwards by 5.26% as well.
Benzinga · 03/27 20:31
Recap: Strata Skin Sciences Q4 Earnings
Strata Skin Sciences reported its Q4 earnings on March 27. The company missed its earnings estimate by $0.04. The firm's revenue was down $1.91 million from the same period last year. Strata skin Sciences is expected to announce its earnings on April 27.
Benzinga · 03/27 20:30
STRATA Skin Sciences GAAP EPS of -$0.11 misses by $0.09, revenue of $8.7M misses by $1.31M
Seeking Alpha · 03/27 20:06
*Strata Skin Sciences 4Q Rev $8.7M >SSKN
Dow Jones · 03/27 20:03
BRIEF-STRATA Skin Sciences Q4 Net Income USD -3.8 Million
Reuters · 03/27 20:01
Press Release: STRATA Skin Sciences Reports -2-
Non-GAAP gross domestic recurring billings represent the amount invoiced to partner clinics when treatment codes are sold to the physician. This excludes international recurring revenues. The company's adjusted EBITDA does not include the impact of goodwill impairment and other charges. Reconciliation of GAAP to XTRAC gross domestic billings to revenue for the third quarter of 2023 and 2022.
Dow Jones · 03/27 20:01
Press Release: STRATA Skin Sciences Reports -3-
Administrative The company has a net loss of $27.7 million. The company's total revenue is $26.9 million. Total losses include losses from operations, interest, and goodwill. The firm's net loss is $21.6 million. In the first quarter of 2013, the company lost $16.7 billion.
Dow Jones · 03/27 20:01
Press Release: STRATA Skin Sciences Reports Fourth Quarter and Full-Year 2023 Earnings
STRATA Skin Sciences Reports Fourth Quarter and Full-Year 2023 Earnings Company to host conference call and webcast today, March 27, 2024, at 4:30 p.m. ET. STRATA skin Sciences reports financial results for the fourth quarter and full-year ended December 31, 2023. Company launched new acne therapy system in January 2023 and implemented a recurring revenue model.
Dow Jones · 03/27 20:01
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Lixte Biotechnology (NASDAQ:LIXT) shares moved upwards by 67.2% to $3.77 during Wednesday's pre-market session. The company's, Q4 earnings came out today. NovoCure stock rose 17.9% and Nutriband shares rose 24.34% in the same session. Akili stock decreased by 20.6% and OpGen stock fell 15.67% during the session.
Benzinga · 03/27 13:05
Earnings Scheduled For March 27, 2024
Local Bounti is projected to report quarterly loss at $2.41 per share on revenue of $8.70 million. Companies Reporting Before The Bell include REE Automotive and Lands' End. The companies are expected to report earnings for their fourth quarter before the bell.
Benzinga · 03/27 09:02
More
Webull provides a variety of real-time SSKN stock news. You can receive the latest news about Strata Skin Sciences Inc through multiple platforms. This information may help you make smarter investment decisions.
About SSKN
STRATA Skin Sciences, Inc. is a medical technology company in dermatology. The Company is engaged in developing, commercializing and marketing products for the treatment of dermatologic conditions. The Company operates through two segments: Dermatology Recurring Procedures and Dermatology Procedures Equipment. The Company’s products include the XTRAC and Pharos excimer lasers and VTRAC lamp systems utilized in the treatment of psoriasis, vitiligo and various other skin conditions. Its products also include the TheraClear Acne Therapy System utilized in the treatment of mild to moderate inflammatory, comedonal and pustular acne. The XTRAC and Pharos excimer laser technology emits highly concentrated ultraviolet (UV) light targeted primarily towards autoimmune dermatological skin disorders, such as psoriasis, vitiligo, atopic dermatitis, and eczema, among others. VTRAC is a UV light lamp system that works in much the same way as the XTRAC.